mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |